Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1995
10/10/1995US5457101 Thieno[1,5]benzoidiazepine use
10/10/1995US5457097 Androst-4-eno[4,5-b]pyrrole derivatives
10/10/1995US5457090 A serine proteolytic enzyme inhibitor
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5457038 Natural killer stimulatory factor
10/10/1995CA1337297C Aminoacylates of glycerol acetal
10/09/1995CA2146600A1 Products with antiglucocorticoid activity used for preparing drugs intended for the prevention or the treatment of manifestations caused by a spontaneous or a precipitated withdrawal symptom due to narcotics or mixtures of narcotics; compositions containing the same
10/06/1995CA2144783A1 Mdr resistance treatment
10/05/1995WO1995026364A1 Monoclonal antibodies recognizing tie-receptor and their use
10/05/1995WO1995026361A1 Vpr AND Vpx PROTEINS OF HIV
10/05/1995WO1995026360A1 Antagonists of endothelin receptors
10/05/1995WO1995026346A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis
10/05/1995WO1995026341A1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors
10/05/1995WO1995026339A1 Salts of substituted heteroaromatic nitrogen compounds, method for their preparation and pharmaceutical compounds containing same
10/05/1995WO1995026338A1 Neurokinin receptor antagonists
10/05/1995WO1995026337A1 Novel carbamates and ureas as modifiers of multi-drug resistance
10/05/1995WO1995026335A1 Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their preparation and pharmaceutical compositions containing same
10/05/1995WO1995026328A1 Biphenyl derivatives as 5ht1d antagonists
10/05/1995WO1995026327A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995WO1995026188A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186606A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995CA2186398A1 Vpr and vpx proteins of hiv
10/05/1995CA2183767A1 Antagonists of endothelin receptors
10/04/1995EP0675201A1 Compositions and methods for stimulating megakaryocyte growth and differentiation
10/04/1995EP0675135A2 Protein PHBP-70, having heparin binding and fibroblast proliferating properties
10/04/1995EP0675134A1 New 20-amino substituted steroid compounds, a method for their production and intermediates therefor and pharmaceutical compositions containing them
10/04/1995EP0675121A1 Novel intermediates and processes for preparing benzothiophene compounds
10/04/1995EP0675120A2 Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
10/04/1995EP0675112A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/04/1995EP0675110A1 1H-Indole-3-glyoxylamide sPLA2 inhibitors
10/04/1995EP0674903A1 Raloxifene for inhibiting bone loss and lowing serum cholesterol
10/04/1995EP0674902A1 Method of improving the immune response
10/04/1995EP0674658A1 A novel protein tyrosine kinase
10/04/1995EP0674639A1 Azanoradamantanes
10/04/1995EP0674638A1 Substituted triols
10/04/1995EP0674627A1 Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors
10/04/1995EP0674626A1 Novel selective aromatase inhibiting compounds
10/04/1995EP0674621A1 Enantiomers of carbazole derivatives as 5-ht1-like agonists
10/04/1995EP0674517A1 Compositions containing caffeine and s(+)-ibuprofen or s(+)-flurbiprofen or s(+)-ketoprofen
10/04/1995EP0674514A1 Use of aryloxyalkyl substituted cyclic amines as calcium channel antagonists and new phenyloxyalkyl piperidin derivatives
10/04/1995EP0674505A1 Synergistic combinations of active substance for the cosmetic or dermatological care of the skin, hair and nails
10/04/1995EP0674484A1 Psyllium drink mix compositions.
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/04/1995CN1109330A Methods of inhibiting imperfect tissue repair
10/03/1995US5455330 Isolated pure protein having specified amino acid sequence
10/03/1995US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/03/1995US5455268 Treating arthropathy
10/03/1995US5455258 Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase
10/03/1995US5455252 Optionally substituted 6,8-quinolines
10/03/1995US5455246 Treating neuropsychiatric disorders
10/03/1995US5455241 Staurosporin derivatives as enzyme inhibitors for protein kinase C and platelet-derived growth factor kinase; antitumor agents, bactericides, antigrowth agents
10/03/1995US5455228 Peptidase resistant thrombin receptor peptide ligand
10/03/1995CA2065093C Remedies for bone diseases
10/03/1995CA1337202C Cyclic amides which are leukotriene antagonists
10/03/1995CA1337200C .beta.-carbolines, their bio-isosteric benzofuran and benzothiophene analogues having cytostatic properties
10/03/1995CA1337177C Bioparyl, a biological regulator, active against various pathologies
10/03/1995CA1337176C Pharmaceutical compositions for the inhibition of tumor metastasis
10/02/1995CA2146085A1 Steroids containing an aminosubstituted chain in position 20; process and intermediates therefor; their use as drugs and pharmaceutical compositions containing them
10/01/1995CA2146059A1 Imidazole-containing inhibitors of farnesyl protein transferase
10/01/1995CA2145960A1 Protein phbp-70
10/01/1995CA2145614A1 Intermediates and processes for preparing benzothiophene compounds
09/1995
09/28/1995WO1995025814A1 Oligonucleotide n3'→p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025736A1 Glucosidic derivatives of n-acyl alkylamines exerting neuroprotective, neurotrophic and anti-inflammatory action, useful in acute and chronic disorders of the central nervous system connected with excitotoxicity
09/28/1995WO1995025727A1 Naphthylamides as central nervous system agents
09/28/1995WO1995025726A1 QUINAZOLINYL-AMINO DERIVATIVES HAVING α-ANTAGONIST ACTIVITY
09/28/1995WO1995025718A1 Vitamin-d amide derivatives
09/28/1995WO1995025537A1 Drug for relieving side effects caused by immunosuppressants
09/28/1995WO1995025533A1 PROTEASOME REGULATION OF NF-λB ACTIVITY
09/28/1995WO1995025526A1 Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
09/28/1995WO1995025524A1 USE OF GINSENOSIDE Ro OR A PLANT EXTRACT CONTAINING SAME TO PROMOTE COLLAGEN SYNTHESIS
09/28/1995WO1995025523A1 Novel pharmaceutical composition for skin diseases
09/28/1995WO1995025522A1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies
09/28/1995WO1995025443A1 Tocolytic oxytocin receptor antagonists
09/28/1995CA2186129A1 Tocolytic oxytocin receptor antagonists
09/28/1995CA2185813A1 Vitamin-d amide derivatives
09/27/1995EP0673934A1 Aminoalkyl benzothiazolinones, process for their preparation and pharmaceutical compositions containing them
09/27/1995EP0673933A1 Aminoalkyl benzoxazolinones and benzothiazolinones process for their preparation and compositions containing them
09/27/1995EP0673932A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673931A1 Sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicaments
09/27/1995EP0673930A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as medicaments
09/27/1995EP0673929A1 Substituted heterocyclic carboxylic acid amides, their preparation and their use as medicaments
09/27/1995EP0673928A1 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
09/27/1995EP0673913A1 Calcium-alkali-citrate compounds and their use as medicaments
09/27/1995EP0673649A1 Pharmaceutical compositions for the prolonged release of trimetazidine after oral administration
09/27/1995EP0673643A1 Cosmetic composition containing an association of superoxide dismutase and porphyrine
09/27/1995EP0673431A1 Gene therapy for cystic fibrosis
09/27/1995EP0673426A1 Platelet-activating factor acetylhydrolase
09/27/1995EP0673388A1 Double chain peptide compounds having hemoregulatory activity
09/27/1995EP0673380A1 Water soluble camptothecin derivatives
09/27/1995EP0673371A1 Benzazepinone derivatives
09/27/1995EP0673369A1 Substituted benzazepinones
09/27/1995EP0673368A1 Novel nicotinic acid esters
09/27/1995EP0673367A1 4-aminomethyl/thiomethyl/sulfonylmethyl-4-phenylpiperidines as tachykinin receptor antagonists
09/27/1995EP0673366A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2
1 ... 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 ... 1564